Impaired Fasting Glucose Is the Major Determinant of the 20‐Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease

BACKGROUND: We wanted to explore the association of metabolic syndrome (MetS) versus its individual components with 20‐year all‐cause mortality among patients with stable coronary artery disease. METHODS AND RESULTS: The cohort comprised 12 403 nondiabetic patients with stable coronary artery diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Younis, Arwa, Goldkorn, Ronen, Goldenberg, Ilan, Geva, Diklah, Tzur, Boaz, Mazu, Anna, Younis, Anan, Fisman, Zvi, Tannenbaum, Alexander, Klempfner, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721758/
https://www.ncbi.nlm.nih.gov/pubmed/29079562
http://dx.doi.org/10.1161/JAHA.117.006609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721758/
https://www.ncbi.nlm.nih.gov/pubmed/29079562
http://dx.doi.org/10.1161/JAHA.117.006609

Ejemplares similares